CureVac N.V. Annual Research And Development Expense in EUR from 2018 to 2023

Taxonomy & unit
ifrs-full: EUR
Summary
CureVac N.V. quarterly/annual Research And Development Expense history and growth rate from 2018 to 2023.
  • CureVac N.V. Research And Development Expense for the quarter ending December 31, 2023 was €33.4M, a 20.8% increase year-over-year.
  • CureVac N.V. Research And Development Expense for the twelve months ending December 31, 2023 was €116M, a 85% increase year-over-year.
  • CureVac N.V. annual Research And Development Expense for 2023 was €116M, a 85% increase from 2022.
  • CureVac N.V. annual Research And Development Expense for 2022 was €62.6M, a 92.3% decline from 2021.
  • CureVac N.V. annual Research And Development Expense for 2021 was €816M, a 617% increase from 2020.
Research And Development Expense, Trailing 12 Months (EUR)
Research And Development Expense, Annual (EUR)
Research And Development Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 116M +53.2M +85% Jan 1, 2023 Dec 31, 2023 20-F 2024-04-25
2022 62.6M -753M -92.3% Jan 1, 2022 Dec 31, 2022 20-F 2024-04-25
2021 816M +702M +617% Jan 1, 2021 Dec 31, 2021 20-F 2024-04-25
2020 114M +70.6M +163% Jan 1, 2020 Dec 31, 2020 20-F/A 2023-10-12
2019 43.2M +1.52M +3.64% Jan 1, 2019 Dec 31, 2019 20-F 2022-04-28
2018 41.7M Jan 1, 2018 Dec 31, 2018 20-F 2021-04-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.